The present application relates to alkoxy-substituted pyridinyl indolsulfonamides. The compounds are negative GPR17 modulators and have utility in the treatment of various GPR17 associated disorders.
SUBSTITUTED ALKOXYPYRIDINYL INDOLSULFONAMIDES
申请人:UCB Pharma GmbH
公开号:EP3584244A1
公开(公告)日:2019-12-25
The present application relates to alkoxy-substituted pyridinyl indolsulfonamides.
The compounds are negative GPR17 modulators and have utility in the treatment of various GPR17 associated disorders.